argus

Lupin Ltd

NSE: LUPININE326A01037₹98,306 Cr

Timeline

Time (IST)TypeMEventSrc
30 Sept, 04:55 pm—…Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
30 Sept, 04:04 pm—…Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Change in Managementbse
30 Sept, 04:00 pm—…Lupin Limited has informed the Exchange about the retirement of Senior Management Personnel of the Company.nse
29 Sept, 06:49 am—…Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Acquisitionbse
29 Sept, 06:44 am—…Lupin Limited has informed the Exchange that Nanomi B.V., the Netherlands, a wholly owned subsidiary of the Company in Netherlands, has entered into a definitive agreement to acquire the entire share capital of VISUfarma B.V., headquartered in Amsterdam, the Netherlands.nse
24 Sept, 04:44 pm—…Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
24 Sept, 04:42 pm—…Lupin Limited has informed the Exchange regarding a press release dated September 24, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Bictegravir, Emtricitabine, andTenofovir Alafenamide Tablets".nse
20 Sept, 01:47 pm—…Lupin Limited has informed the Exchange about U.S. FDA has conducted a product-specific Pre-Approval Inspection at the Company s Pune Biotech facility.nse
17 Sept, 01:08 pm—…Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
17 Sept, 01:05 pm—…Lupin Limited has informed the Exchange regarding a press release dated September 17, 2025, titled "Lupin Receives Approval from U.S. FDA for Lenalidomide Capsules".nse
16 Sept, 09:22 pm—…Lupin Limited has informed the Exchange about U.S. FDA has conducted an inspection of Company s Injectable facility at Nagpur.nse
13 Sept, 12:12 pm—…Lupin Limited has informed the Exchange about ESG Rating by ESG Risk Assessments and Insights Limited.nse
11 Sept, 12:12 pm—…Lupin Limited has informed the Exchange about Schedule of Analyst/Institutional Investors Meet.nse
06 Sept, 09:07 am—…Lupin Limited has informed the Exchange regarding 'U.S. FDA has conducted a product-specific Pre-Approval Inspection at the Company s Chhatrapati Sambhajinagar (Aurangabad) manufacturing facility '.nse
03 Sept, 01:04 pm—…Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
03 Sept, 01:03 pm—…Lupin Limited has informed the Exchange regarding a press release dated September 03, 2025, titled "Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi s Long-Acting Injectable Platform".nse